Background: The use of probiotics for the prevention of antibiotic-associated diarrhea (AAD)
is supported by the results of several meta-analyses; however, most of the studies included …

Background Convincing evidence that probiotic administration can lower the risk of antibiotic‐
associated diarrhoea is limited to certain micro‐organisms. Aim To determine the efficacy of …

Abstract Background/Aims: The incidence of pediatric inflammatory bowel disease (IBD) in
Western countries is on the rise. No prospective studies have been conducted on the …

Dysbiosis plays a major role in the etiology of inflammatory bowel disease (IBD). Fecal
microbiota transplantation (FMT) is a new promising option for IBD treatment. We aimed to …

ABSTRACT Purpose Eosinophilic esophagitis (EoE) is a chronic disease characterized by
eosinophilic infiltration of the esophageal mucosa, which is associated with clinical and …

The prevalence of Clostridium difficile infection (CDI) in pediatric patients with inflammatory
bowel disease (IBD) is still not sufficiently recognized. We assessed the prevalence of CDI …

Introduction. Small intestine bacterial overgrowth (SIBO) has been reported in cystic fibrosis
(CF) patients. However, the potential link to intestinal inflammation has not been studied so …

Background and aims: Clostridium difficile is the major cause of antibiotic-associated
diarrhea and is the most well known bacterial pathogen associated with inflammatory bowel …

Background There are only a few studies on immune response to routine vaccinations in
children with inflammatory bowel disease (IBD), despite a strong need for this kind of study …

Previously published studies have indicated that gastroesophageal reflux (GER) disease is
common in pediatric patients with cystic fibrosis. The aim of the present study was to get …